Form 8-K - Current report:
SEC Accession No. 0001157523-21-001027
Filing Date
2021-08-09
Accepted
2021-08-09 09:00:29
Documents
2
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EDGEWISE THERAPEUTICS, INC. FORM 8-K a52473423.htm 8-K 23167
2 EXHIBIT 99.1 a52473423ex99_1.htm EX-99.1 62829
  Complete submission text file 0001157523-21-001027.txt   87087
Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 211154815
SIC: 2834 Pharmaceutical Preparations